{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:44:30Z","timestamp":1792352670026,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.eprac.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:59:15Z","timestamp":1731445155000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Features and Hormonal Profile of Macroprolactinomas Presenting With the Hook Effect: A Systematic Review"],"prefix":"10.1016","volume":"31","author":[{"given":"Muhannad M.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith M.","family":"Haj-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil William G.","family":"Sweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Nsour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah T.","family":"Al-Ani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Oran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Khlefat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Aqel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eprac.2024.11.002_bib1","doi-asserted-by":"crossref","DOI":"10.1530\/EC-18-0250","article-title":"Management of prolactinoma: a survey of endocrinologists in China","volume":"7","author":"Ji","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2024.11.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.eprac.2024.11.002_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcs240","article-title":"Macroprolactinoma: a diagnostic and therapeutic update","volume":"106","author":"Iglesias","year":"2013","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.eprac.2024.11.002_bib4","doi-asserted-by":"crossref","DOI":"10.1159\/000141512","article-title":"Misdiagnosis due to the hook effect in prolactin assay","volume":"17","author":"Yener","year":"2008","journal-title":"Med Princ Pract"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4158\/EP.8.4.296","article-title":"\u201cHook effect\u201d in prolactinomas: case report and review of literature","volume":"8","author":"Frieze","year":"2002","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.002_bib6","article-title":"Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of \u201chook effect.\u201d","volume":"79","author":"Fleseriu","year":"2006","journal-title":"J\u00a0Neuro Oncol"},{"issue":"2","key":"10.1016\/j.eprac.2024.11.002_bib7","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-06-0646","article-title":"Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men","volume":"156","author":"Shimon","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2024.11.002_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib9","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2265.1996.663486.x","article-title":"High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas","volume":"44","author":"St-Jean","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.11.002_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.eprac.2024.11.002_bib11","article-title":"Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Br Med J"},{"key":"10.1016\/j.eprac.2024.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-119-2-199307150-00029","article-title":"Immunoradiometric assays may miss high prolactin levels","author":"Comtois","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2265.1996.t01-1-00826.x","article-title":"Potential hook effect in prolactin assay in patients with giant prolactinoma","volume":"45","author":"Delgrange","year":"1996","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF03347299","article-title":"Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect","volume":"21","author":"Petakov","year":"1998","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006123-199804000-00126","article-title":"Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the \u201chigh-dose hook effect\u201d: case report","volume":"42","author":"Barkan","year":"1998","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.eprac.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.55.9.1415","article-title":"Giant prolactinoma and hook effect","volume":"55","author":"Pakzaban","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.002_bib17","first-page":"78","article-title":"The \u201chook effect\u201d on serum prolactin estimation in a patient with macroprolactinoma","volume":"49","author":"Unnikrishnan","year":"2001","journal-title":"Neurol India"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1025334001748","article-title":"Falsely low serum prolactin in two cases of invasive macroprolactinoma","volume":"5","author":"Sch\u00f6fl","year":"2002","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.eprac.2024.11.002_bib19","first-page":"656","article-title":"The hook effect in prolactin immunoassays","volume":"25","author":"AI Sifri","year":"2004","journal-title":"Saudi Med J"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000326184","article-title":"Giant invasive pituitary adenoma extending into the sphenoid sinus and nasopharynx","volume":"49","author":"Inagawa","year":"2005","journal-title":"Acta Cytol"},{"key":"10.1016\/j.eprac.2024.11.002_bib21","article-title":"High-dose hook effect in patients with macroprolactinoma","author":"Kim","year":"2005","journal-title":"J Korean Soc Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2024.11.002_bib22","first-page":"148","article-title":"Megadenoma","volume":"20","author":"Field","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.4076\/1757-1626-2-6449","article-title":"Hyperthyroidism unmasked several years after the medical and radiosurgical treatment of an invasive macroprolactinoma inducing hypopituitarism: a case report","volume":"2","author":"Foppiani","year":"2009","journal-title":"Cases J"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02688690802535081","article-title":"Hydrocephalus caused by giant pituitary tumors: case series and guidelines for management","volume":"23","author":"Joshi","year":"2009","journal-title":"Br J Neurosurg"},{"issue":"8","key":"10.1016\/j.eprac.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0004-27302010000800017","article-title":"Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene","volume":"54","author":"Naves","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib26","doi-asserted-by":"crossref","first-page":"E874","DOI":"10.1227\/NEU.0b013e318207ac0b","article-title":"Clinical problem solving: monster on the hook\u2014case problems in neurosurgery","volume":"68","author":"Muh","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.eprac.2024.11.002_bib27","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.32.P707","article-title":"Prevalence and clinical significance of hook-effect and macroprolactinaemia phenomenons in patients with prolactinomas","author":"Nasybullina","year":"2013","journal-title":"Endocr Abstr"},{"key":"10.1016\/j.eprac.2024.11.002_bib28","article-title":"PS 0198; Endocrinology: giant cystic prolactinoma in a woman: do not forget the hook effect","author":"Gutierrez","year":"2014","journal-title":"\ub300\ud55c\ub0b4\uacfc\ud559\ud68c \ucd94\uacc4"},{"key":"10.1016\/j.eprac.2024.11.002_bib29","article-title":"\u2019High dose hook effect\u2019in a patient with invasive giant prolactinoma","author":"Ogmen","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2024.11.002_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.12688\/f1000research.3062.1","article-title":"Case report: reversible cabergoline-associated cardiac valvulopathy post drug discontinuation","volume":"3","author":"Yedinak","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.eprac.2024.11.002_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13339","article-title":"Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma","author":"Bulwer","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.11.002_bib32","article-title":"Response to Cabergoline treatment in Invasive Prolactinoma with hemorrhage-A case report","author":"Pant","year":"2017","journal-title":"J Diabetes"},{"issue":"11","key":"10.1016\/j.eprac.2024.11.002_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/ccr3.1208","article-title":"Chronic cluster-like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?","volume":"5","author":"Pineyro","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.eprac.2024.11.002_bib34","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-18-0099","article-title":"Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline","author":"Almistehi","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.eprac.2024.11.002_bib35","doi-asserted-by":"crossref","DOI":"10.25179\/tjem.20182202-P059","article-title":"Postmenopausal hook effect","author":"\u00c7olak","year":"2018","journal-title":"Turkish J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib36","first-page":"e49","article-title":"Pituitary macroprolactinoma with mildly elevated serum prolactin: hook effect","volume":"2","author":"Pejman Sani","year":"2018","journal-title":"Adv J Emerg Med"},{"key":"10.1016\/j.eprac.2024.11.002_bib37","article-title":"Clinical outcome of invasive pituitary prolactinomas treated with cabergoline","author":"Arkawazi","year":"2019","journal-title":"AL-Kindy College Medical J"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4158\/EP-2018-0392","article-title":"ksana, Gompel J Van, Gruber L, Kittah NE, et al. Management and outcomes of giant prolactinoma: a series of 71 patients","volume":"25","author":"Hamidi","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.11.002_bib39","article-title":"Untreated giant macroprolactinoma with chronic cerebrospinal fluid leakage: an unusual complication","author":"Naser","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.eprac.2024.11.002_bib40","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab048.1258","article-title":"Underappreciation of the \u201chook effect\u201d leading to mismanagement of a patient, a tale of preventable disaster","author":"Amini","year":"2021","journal-title":"J Endocrine Soc"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.11.002_bib41","article-title":"SAT604 an extensively invasive giant prolactinoma associated with CDH23 mutation","volume":"7","author":"Alghamdi","year":"2023","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.eprac.2024.11.002_bib42","first-page":"1990259","article-title":"Surgical management of giant prolactinomas: a descriptive study","volume":"2023","author":"Lundholm","year":"2023","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.eprac.2024.11.002_bib43","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.90.EP725","article-title":"Coexistence of PRL-secreting adenoma and germ cell tumor in 14-year-old adolescent","author":"Kalinin","year":"2023","journal-title":"Endocr Abstr"},{"issue":"9","key":"10.1016\/j.eprac.2024.11.002_bib44","first-page":"e46194","article-title":"Rassier isolan G. The hook effect: a case study of a giant invasive prolactinoma with falsely low serum prolactin","volume":"15","author":"Gon\u00e7alves","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.eprac.2024.11.002_bib45","first-page":"13","article-title":"Clinical features, therapeutic trends, and outcome of giant prolactinomas: a single-center experience over a 12-year period","author":"Almalki","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-018-1645-x","article-title":"Giant pituitary adenoma: histological types, clinical features and therapeutic approaches","volume":"61","author":"Iglesias","year":"2018","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib47","article-title":"Update in prolactinomas","volume":"68","author":"Kars","year":"2010","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-015-0791-7","article-title":"Giant prolactinomas: are they really different from ordinary macroprolactinomas?","volume":"52","author":"Espinosa","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2024.11.002_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-014-0563-z","article-title":"Hypopituitarism patterns and prevalence among men with macroprolactinomas","volume":"18","author":"Tirosh","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.eprac.2024.11.002_bib50","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.35.P845","article-title":"NFPA and hypopituitarism: a retrospective analysis of 260 patients and focus on the prevalence of isolated hypoadrenalism","author":"Carosi","year":"2014","journal-title":"Endocr Abstr"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-022-01242-y","article-title":"Proportion and predictors of hypogonadism recovery in men with macroprolactinomas treated with dopamine agonists","volume":"25","author":"Al Dahmani","year":"2022","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.eprac.2024.11.002_bib52","article-title":"Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature","volume":"44","author":"Di Somma","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.eprac.2024.11.002_bib53","article-title":"Gender-related differences in prolactinomas. A clinicopathological study","volume":"26","author":"Schaller","year":"2005","journal-title":"Neuroendocrinol Lett"},{"issue":"3","key":"10.1016\/j.eprac.2024.11.002_bib54","article-title":"Gender diffrences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2024.11.002_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-022-01246-8","article-title":"Prolactin immunoassay: does the high-dose hook effect still exist?","volume":"25","author":"Raverot","year":"2022","journal-title":"Pituitary"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T23:21:12Z","timestamp":1740612072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24008267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1530891X24008267"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.11.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Features and Hormonal Profile of Macroprolactinomas Presenting With the Hook Effect: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}